SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs rally to fresh highs is drawing attention after bullish analyst upgrades tied to growth in sovereign AI and customized software. Bulls are celebrating the breakout and speculating about a squeeze, while bears argue the valuation is stretched and warn of a pullback.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas Nasdaq-100 reentry and expected index-fund buying, alongside optimism about an NIH-backed cancer-vaccine initiative and its Merck-partnered melanoma-vaccine results, are driving attention. Bulls point to pipeline potential and momentum, while skeptics argue the rally has outpaced the companys fundamentals and could give way to profit-taking.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is drawing attention after the lockup expiration made previously restricted shares tradable, with traders debating whether added supply and a premium-to-NAV valuation are driving the sharp volatility. Bulls still frame the fund as a way to gain exposure to Anthropic ahead of a potential IPO, while bears focus on dilution, selling pressure, and whether the funds reported NAV supports its market price.

Tidal Trust II - YieldMax MSTR Option Income Strategy ETF

YieldMax MSTR Option Income Strategy ETF

MSTY is drawing attention for its variable weekly distributions and price swings tied to MicroStrategy and Bitcoin. Bulls welcome the income and potential recovery if BTC and MSTR strengthen, while skeptics point to falling payouts and NAV erosion.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

SpaceXs planned acquisition of Grain Managements 800 MHz spectrum portfolio has intensified concerns that Starlink Mobile could eventually compete with T-Mobile and other U.S. carriers, contributing to a sharp TMUS selloff. Traders are divided between viewing the deal as a long-term competitive threat and calling the market reaction excessive, arguing that building a viable terrestrial network would take substantial time and investment.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumbles reported multi-year Anthropic compute deal and expansion into AI infrastructure through Northern Data and the Maysville data center dominate discussion. Bulls see major growth potential and point to high short interest, while skeptics focus on financing, execution, and whether the contract will translate into operating revenue.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

A biotech-vaccine rallyalongside renewed focus on Novavaxs Sanofi partnership and regulatory progress toward a Phase 3 COVID/flu combination trialis driving attention. Traders are watching for the trial start that could trigger a milestone payment, while short-squeeze claims fuel bullish chatter and skeptics question whether the gains will hold.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflakes strong quarterly results and raised outlook, attributed to accelerating platform consumption and AI adoption, are driving attention. Bulls view the results as evidence that enterprise AI is boosting demand, while skeptics point to the companys high valuation and lack of GAAP profitability and expect gains to face profit-taking.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

DOTs sharp rebound from recent lows is driving attention, with traders debating whether it marks a durable recovery or a short-lived bounce in a token still far below past highs. Bullish posts point to Polkadot upgrades and tokenomics changes, while skeptics emphasize weak demand and the prolonged downtrend.

Valero Energy Corp. engages in the manufacture and marketing of transportation fuels and other petrochemical products. It operates through the following business segments: Refining, Ethanol and Renewable Diesel. The Refining segment consists of refining operations, associated marketing activities, and logistics assets that support its refining operations. The Ethanol segment includes its ethanol operations, associated marketing activities, and logistics assets that support its ethanol operations. The Renewable Diesel covers the operations of Diamond Green Diesel Holdings LLC. The company was founded in 1980 and is headquartered in San Antonio, TX.

Valero Energy Corp.

Tight diesel supply and unusually strong refining crack spreads amid energy-market disruptions are driving attention to Valero and other refiners. Traders remain divided between the strong margin backdrop and concerns about profit-taking, stretched valuations, and possible diesel export restrictions that could alter refining economics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Transcript: Ascentage Pharma Group H1 2026 Earnings Conference Call

On Thursday, Ascentage Pharma Group (NASDAQ:AAPG) discussed quarterly financial results during its earnings call. The full transcript is provided below.
This content is powered by Benzinga APIs. For comprehensiveread more...

Wall Street Analysts Predict a 160.09% Upside in Ascentage Pharma Group International - Unsponsored ADR (AAPG): Here's  What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 160.1% in Ascentage Pharma Group International - Unsponsored ADR (AAPG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

How Much Upside is Left in Ascentage Pharma Group International - Unsponsored ADR (AAPG)? Wall Street Analysts Think 152.23%

The consensus price target hints at a 152.2% upside potential for Ascentage Pharma Group International - Unsponsored ADR (AAPG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - Time to Sell?

Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - What's Next...

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Short Interest Down 51.1% in April

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) was the recipient of a significant decrease in short interest in April. As of April 15th, there was short...

Ascentage Pharma Group International (NASDAQ:AAPG) Sees Large Volume Increase  - Here's Why

Ascentage Pharma Group International (NASDAQ:AAPG) Sees Unusually-High Trading Volume - Should You Buy...

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Receives Consensus Recommendation of "Buy" from Analysts

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) has received an average rating of "Buy" from the seven brokerages that are presently covering the stock...

Ascentage Pharma Group International (NASDAQ:AAPG) Shares Down 8.4% - What's Next?

Ascentage Pharma Group International (NASDAQ:AAPG) Trading Down 8.4% - What's Next...

Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - What's Next?

Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - Here's Why...

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Short Interest Update

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 1,470 shares, an increase of 54.6% from the March 15th total of 951 shares...

Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.

Ascentage Pharma Group International - ADR

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

AAPG Ascentage Pharma Group International - ADR

Fundamentals

Latest AAPG News